MSCV-mir-17-92 Citations (2)

Originally described in: A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis.
Olive V, Sabio E, Bennett MJ, De Jong CS, Biton A, McGann JC, Greaney SK, Sodir NM, Zhou AY, Balakrishnan A, Foth M, Luftig MA, Goga A, Speed TP, Xuan Z, Evan GI, Wan Y, Minella AC, He L Elife. 2013 Oct 15;2:e00822. doi: 10.7554/eLife.00822. PubMed Journal

---

Articles Citing MSCV-mir-17-92

Articles
Mir-17 approximately 92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration. Tung YT, Peng KC, Chen YC, Yen YP, Chang M, Thams S, Chen JA. Cell Stem Cell. 2019 Aug 1;25(2):193-209.e7. doi: 10.1016/j.stem.2019.04.016. Epub 2019 May 30. PubMed
Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression. Guo Y, Ye Q, Deng P, Cao Y, He D, Zhou Z, Wang C, Zaytseva YY, Schwartz CE, Lee EY, Mark Evers B, Morris AJ, Liu S, She QB. Nat Commun. 2020 Jun 26;11(1):3243. doi: 10.1038/s41467-020-17067-x. PubMed

If you have published an article using this material, please email us at to have your article added to this page.